Trimix HIGH recalled over sterility concerns

Recall date

April 8, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Customceutical Compounding recalls Trimix HIGH (Papaverine HCl 30 mg/mL Phentolamine Mesylate 2 mg/mL Alprostadil 20 mcg/mL), 2 mL multidose vial MDV Inj.…

Recall number

D-1261-2019

FDA classification

Class II

Brand / firm

Customceutical Compounding

Sold / distributed

U.S.A. Nationwide

Why it was recalled

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Trimix HIGH (Papaverine HCl 30 mg/mL Phentolamine Mesylate 2 mg/mL Alprostadil 20 mcg/mL), 2 mL multidose vial MDV Inj. Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272